[Generic Drug Price Reform] ② The Paradox of Drug Price Reduction: Even with Lower Prices, 'Zero Perceived Change' and Growing Supply Instability

South Korea is set to implement a reduction in insurance prices for generic and off-patent medications beginning in August. This policy aims to make essential medicines more affordable, aligning with government efforts to manage healthcare costs.

Despite the planned price adjustments, a significant concern is that patients might not experience a noticeable decrease in their out-of-pocket expenses. The complexity of pharmaceutical pricing and insurance reimbursement structures could obscure the intended benefits for the end consumer.

Furthermore, the policy shift is expected to place a considerable burden on pharmacies regarding inventory settlement. This administrative challenge could be compounded by worries that reduced profitability for essential, lower-margin drugs might exacerbate existing supply chain issues, potentially leading to recurring shortages of critical medications.